Piamarie Ballarin-feldman, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 47 Ashby State Road, Tmg Primary Care Suite 102, Fitchburg, MA 01420 Phone: 978-345-0303 Fax: 978-345-3529 |
Jeff J Wang, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 275 Nichols Rd, Fitchburg, MA 01420 Phone: 978-878-8374 |
James E Fluet, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 155 Franklin Rd, Fitchburg, MA 01420 Phone: 978-345-1919 Fax: 978-342-6240 |
Kate Cochrane Cosgrove, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 370 Lunenburg St, Fitchburg, MA 01420 Phone: 978-342-6018 Fax: 978-348-1286 |
Mrs. Michelle G Gasbarro, MS,APRN,FNP,BC Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 47 Ashby State Rd, Fitchburg, MA 01420 Phone: 978-345-1040 Fax: 978-348-1286 |
John Herbert Stevenson Ii, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 275 Nichols Rd, Fitchburg, MA 01420 Phone: 978-878-8100 Fax: 978-665-5808 |
Dr. Cheryl T Divito, D.O. Family Medicine Medicare: May Accept Medicare Assignments Practice Location: 326 Nichols Rd, Fitchburg, MA 01420 Phone: 978-343-5270 Fax: 978-343-5390 |
News Archive
GTx, Inc. today reported financial results for the third quarter of 2009. The net loss for the third quarter and nine months ended September 30, 2009 was $12.8 million and $35.4 million, respectively, compared with a net loss of $11.9 million and $37.9 million for the same periods in 2008. At September 30, 2009 GTx had cash, cash equivalents and short-term investments of $55.5 million.
Infinity Pharmaceuticals, Inc. announced that results from its Phase 2 study of IPI-504, a novel IV-administered Hsp90 chaperone inhibitor, in patients with advanced non-small cell lung cancer (NSCLC) were published in the Journal of Clinical Oncology.
Most HGTV fans will agree that good design can improve one's state of mind. Designers at The Johns Hopkins Hospital in Baltimore also believe it can help patients heal, which is why its new 1.6 million square-foot patient care building, scheduled to open in April 2012, features an elegant design with peace and quiet for patients as a priority.
The drug daclatasvir (trade name Daklinza) has been available since August 2014 for the treatment of adults with chronic hepatitis C (CHC) infection. The German Institute for Quality and Efficiency in Health Care examined in a dossier assessment whether this new drug offers an added benefit over the appropriate comparator therapy.
› Verified 8 days ago